Natriumhydrogencarbonat- Lösung Köhler (Sodium Hydrogen Carbonate)

Sodium hydrogen carbonate, the active ingredient in Natriumhydrogencarbonat- Lösung Köhler, is an excipient presented as a solution for injection for intravenous use. It provides bicarbonate ions to buffer systemic pH in patients requiring electrolyte management. The product complies with EU pharmacopeial standards and is manufactured under GMP conditions.

GNH USA supplies Natriumhydrogencarbonat- Lösung Köhler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company’s distribution network covers North America, Europe, Asia‑Pacific and the Middle East, ensuring timely delivery to critical care settings.

Sodium hydrogen carbonate injection is used to manage disorders of acid‑base balance and electrolyte disturbances. - Metabolic acidosis: restores plasma bicarbonate levels to correct systemic acidemia. - Renal tubular acidosis: provides bicarbonate to compensate for renal loss of base. - Hyperkalemia: promotes intracellular shift of potassium, aiding rapid potassium reduction. - Cardiac arrest (ACLS): used as part of resuscitation protocols to counteract acidemia. - Certain drug overdoses (e.g., tricyclic antidepressants): alkalinizes urine to enhance drug elimination.

Intravenous administration of sodium hydrogen carbonate may be associated with several adverse reactions.

Common Side Effects: - Hypernatremia: elevated serum sodium. - Metabolic alkalosis: excessive increase in blood pH. - Local irritation: pain or erythema at the infusion site.

Serious or Rare Side Effects: - Severe alkalosis: may cause respiratory depression or seizures. - Cardiac arrhythmias: due to rapid potassium shifts. - Anaphylactic reaction: rare hypersensitivity.

When using sodium hydrogen carbonate injection, clinicians should observe several safety considerations. - Renal impairment: monitor serum electrolytes and acid‑base status closely. - Cardiac disease: avoid rapid infusion in patients with heart failure or arrhythmias. - Fluid balance: assess volume status to prevent overload. - Concomitant potassium‑lowering agents: watch for profound hypokalemia. - Pregnancy and lactation: use only if benefit outweighs potential risk, as data are limited. - Store below 25°C: keep in original container, protect from moisture and light.

Sodium hydrogen carbonate can interact with several medications, altering electrolyte or acid‑base balance.

Major Interactions (Avoid): - Insulin therapy: may cause rapid intracellular potassium shift leading to severe hypokalemia. - Loop diuretics: additive risk of electrolyte depletion and alkalosis. - Sodium‑containing medications: increase risk of hypernatremia and fluid overload.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor for hyperkalemia when used together. - Aminoglycoside antibiotics: watch renal function and electrolyte status. - Carbonic anhydrase inhibitors (e.g., acetazolamide): may reduce the buffering effect of bicarbonate.